Posts Tagged: breast cancer


The Unpredictable Prospects of Patenting Cancer Innovation

Art Unit 1618 and 1621 are both identified as relating to “organic compounds – part of the class 532-570 series.” However, the patenting probability for cancer related applications is markedly …

Patent-Ineligibility of Medical Diagnostics, Life Sciences Discoveries Arrests U.S. Progress

In a research project funded by the Austrian Science Fund (FWF), evidence emerged that a higher expression of the GIRK1 protein in malignant tissue samples was linked …
By Steve Brachmann
2 years ago 3

Blue Ribbon Panel of Advisors Announced for Biden Cancer Moonshot Initiative

Earlier this week the National Cancer Institute (NCI), which is part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, …
By Gene Quinn
4 years ago 5

Bolder initiatives needed to take next steps in fight against cancer

February 4 is World Cancer Day... There has been steady progress made in the history of treating cancers of many types since the administration of former U.S …
By Steve Brachmann
4 years ago 4

Federal funding for a cancer moonshot is not a terrible idea

To hear Ars Technica say it is ''a terrible idea'' to devote increased funding in order to eradicate cancer is astonishing on many levels. As part of …

General Electric beats recent earnings estimates, focuses on healthcare and energy R&D

Medical and healthcare technologies were again prevalent when taking a survey of GE patent applications recently published by the USPTO. Techniques for determining a better course of …
By Steve Brachmann
4 years ago 0

Despite diminishing resources HBCUs contribute to medical innovations

Research and development of cancer treatments seemed to be a particularly strong focus area for Morehouse School of Medicine. A pharmaceutical composition designed to modulate receptors within …
By Steve Brachmann
5 years ago 0

Merck seeks patents on cancer treatments, medications for Alzheimer’s

Merck & Co. (NYSE: MRK), which is headquartered in Whitehouse Station, NJ, and also does business under the name Merck Sharp & Dohme MSD, is one of …
By Steve Brachmann
5 years ago 0

A Passionate Fight Against Breast Cancer

She thought about a new approach to get these patents off the shelf: launching an international competition for teams to develop business plans for a start-up company …
By Joseph Allen
5 years ago 0

Pharma & Biotech Update: News for October 2013

Mouse Model of Parkinson's Disease Shows Improved Brain Function --- DARPA Awards $25 Million To Develop Messenger RNA Therapeutics™ --- Actavis Files ANDA for Generic Suboxone® Sublingual Film …
By Gene Quinn
6 years ago 2

Patent Pending: Corporations, the Constitution, and the Human Gene

The Honorable Alex Kozinski immediately posed the question—by way of an analogy to scientists who stare at the stars—of why should someone be able to …
By Robin Feldman
7 years ago 3

Gene Patents: Getting Beyond Witch Trials

The USPTO Roundtable on genetic testing exposed claims that have driven the debate so far to a rare scrutiny.  Perhaps the bonfires being prepared for the accused …
By Joseph Allen
7 years ago 1

Patent Granted on Long-Acting Drug for Multiple Sclerosis

The conjugates covered by this patent could enable less frequent and better tolerated dosing of one of the most widely used treatments worldwide for relapsing-remitting multiple sclerosis, …
By Gene Quinn
7 years ago 0

US Oncologists Report Crucial Cancer Drug Shortages

The mantra of the anti-patent community is nearly in unison on the issue of patented drugs. Of course, everyone wants drugs to be developed, but no one …
By Gene Quinn
7 years ago 0

FDA: No to Breast Cancer Drug, Could Cost Genetech $1 Billion

Contrary to the FDA, the European Medicines Agency confirmed that the benefits of Avastin® in combination with paclitaxel outweigh the risks, further determining that the combination of …
By Gene Quinn
9 years ago 0